Content about CAMBRIDGE

March 18, 2014

A new study published in the March 18 journal Annals of Internal Medicine raises questions about current guidelines which generally restrict the consumption of saturated fats and encourage consumption of polyunsaturated fats, or fish oils, to prevent heart disease.

CAMBRIDGE, England — A new study published in the March 18 journal Annals of Internal Medicine raises questions about current guidelines which generally restrict the consumption of saturated fats and encourage consumption of polyunsaturated fats, or fish oils, to prevent heart disease. 

"These are interesting results that potentially stimulate new lines of scientific inquiry and encourage careful reappraisal of our current nutritional guidelines," suggested Rajiv Chowdhury, lead author of the research at the University of Cambridge.

March 3, 2014

An international team led by researchers at the Broad Institute and Massachusetts General Hospital has identified mutations in a gene that can reduce the risk of developing Type 2 diabetes, even in people who have such risk factors as obesity and old age, the group announced Sunday.

CAMBRIDGE, Mass. — An international team led by researchers at the Broad Institute and Massachusetts General Hospital has identified mutations in a gene that can reduce the risk of developing Type 2 diabetes, even in people who have such risk factors as obesity and old age, the group announced Sunday. The results focus the search for developing novel therapeutic strategies for Type 2 diabetes — if a drug can be developed that mimics the protective effect of these mutations, it could open up new ways of preventing this devastating disease.

February 18, 2014

Novartis on Monday announced that it is broadening its cancer immunotherapy research program with the acquisition of CoStim Pharmaceuticals, a Cambridge, Mass.-based, privately held biotechnology company focused on harnessing the immune system to eliminate immune-blocking signals from cancer.

BASEL, Switzerland — Novartis on Monday announced that it is broadening its cancer immunotherapy research program with the acquisition of CoStim Pharmaceuticals, a Cambridge, Mass.-based, privately held biotechnology company focused on harnessing the immune system to eliminate immune-blocking signals from cancer.

February 7, 2014

A new and possibly transformative technology for rapidly diagnosing and evaluating patients based on their specific genetic profile may soon begin appearing at retail pharmacies and clinics, giving pharmacists and clinicians another tool for advancing patient health outcomes and their own practice capabilities.

A new and possibly transformative technology for rapidly diagnosing and evaluating patients based on their specific genetic profile may soon begin appearing at retail pharmacies and clinics, giving pharmacists and clinicians another tool for advancing patient health outcomes and their own practice capabilities.

Dr. Anita Goel, M.D., Ph.D.

January 24, 2014

Social media-savvy adults with health conditions would be willing to share their health data online if it helps clinicians improve care, helps other patients or advances medical research, according to a recent survey by PatientsLikeMe, a patient network and real-time research platform.

CAMBRIDGE, Mass. — Social media-savvy adults with health conditions would be willing to share their health data online if it helps clinicians improve care, helps other patients or advances medical research, according to a recent survey by PatientsLikeMe, a patient network and real-time research platform.

January 23, 2014

Anoka-Ramsey Community College announced that it will offer an associate in science degree in Pharmacy Technician. The required general education courses for the new program can be taken at either the Cambridge or Coon Rapids locations.

CAMBRIDGE, Minn. — Anoka-Ramsey Community College announced that it will offer an associate in science degree in pharmacy technician. The required general education courses for the new program can be taken at either the Cambridge or Coon Rapids locations.

Program-specific courses are held at the Cambridge campus to help meet the needs of area pharmacies, according to the college.

January 15, 2014

Zafgen on Wednesday announced initial results from its Phase 2a study of beloranib, a selective inhibitor of methionine aminopeptidase 2 (MetAP2), in patients with Prader-Willi syndrome, a severe form of genetic obesity.

CAMBRIDGE, Mass — Zafgen on Wednesday announced initial results from its Phase 2a study of beloranib, a selective inhibitor of methionine aminopeptidase 2 (MetAP2), in patients with Prader-Willi syndrome, a severe form of genetic obesity. These results showed improvements in body weight, hunger-related behaviors and body composition, including reductions in body fat content and preserved lean body mass following four weeks of treatment. 

January 3, 2014

Adults who are covered by Medicaid use emergency rooms 40% more than those in similar circumstances who do not have health insurance, according to a new study, co-authored by an MIT economist, that sheds empirical light on the inner workings of health care in the United States.

CAMBRIDGE, Mass. — Adults who are covered by Medicaid use emergency rooms 40% more than those in similar circumstances who do not have health insurance, according to a new study co-authored by an MIT economist that sheds empirical light on the inner workings of health care in the United States.

The study takes advantage of Oregon's recent use of a lottery to assign access to Medicaid, the government-backed healthcare plan for low-income Americans, to certain uninsured adults. The research examines emergency room records for roughly 25,000 people for a period of 18 months.

December 30, 2013

The Food and Drug Administration has declined to approve a drug made by Genzyme Corp. for certain forms of multiple sclerosis, the company said Monday.

CAMBRIDGE, Mass. — The Food and Drug Administration has declined to approve a drug made by Genzyme Corp. for certain forms of multiple sclerosis, the company said Monday.

December 23, 2013

The Food and Drug Administration has approved revisions to the labeling of a leukemia drug made by Ariad Pharmaceuticals that allow the company to resume selling it, the company said.

CAMBRIDGE, Mass. — The Food and Drug Administration has approved revisions to the labeling of a leukemia drug made by Ariad Pharmaceuticals that allow the company to resume selling it, the company said.

December 12, 2013

A new product is designed to provide babies with neck support and comfort while they're in the seated position.

CAMBRIDGE, Minn. — A new product is designed to provide babies with neck support and comfort while they're in the seated position.

Baby Elephant Ears, invented by mother Alicia Overby, provide spinal and neck alignment and can be placed behind babies' necks while they're in the stroller, swing, car seat or on the changing table.

December 9, 2013

Swiss drug maker Novartis is providing a vaccine to Princeton University amid an outbreak of potentially fatal meningitis that has affected at least eight students, the university said Monday.

CAMBRIDGE, Mass. — Swiss drug maker Novartis is providing a vaccine to Princeton University amid an outbreak of potentially fatal meningitis that has affected at least eight students, the university said Monday.

October 10, 2013

QS/1 will offer its pharmacy clients prescription-translation software under a new partnership with pharmacy language service firm RxTran, the two companies said Thursday.

CAMBRIDGE, Mass. — QS/1 will offer its pharmacy clients prescription-translation software under a new partnership with pharmacy language service firm RxTran, the two companies said Thursday.

September 23, 2013

Results from a new survey released Monday of 5,256 PatientsLikeMe members who live day to day with life-changing conditions found that nearly one-third of respondents never (5%) or rarely (25%) get a good night’s sleep.

CAMBRIDGE, Mass. — Results from a new survey released Monday of 5,256 PatientsLikeMe members who live day to day with life-changing conditions found that nearly one-third of respondents never (5%) or rarely (25%) get a good night’s sleep. Nearly half (44%) wake up a lot during the night every night, or almost every night.

The survey also found that sleep problems for the group are chronic, with more than half (53%) saying their sleep problems have lasted for more than a year. 

August 22, 2013

Novartis said Wednesday it would ship a "minimum" of 30 million doses of seasonal flu vaccine to customers in the United States this season.

CAMBRIDGE, Mass. — Novartis said Wednesday it would ship a "minimum" of 30 million doses of seasonal flu vaccine to customers in the United States this season.

August 2, 2013

The Food and Drug Administration has approved a vaccine against meningococcal disease for use among patients of a broader age range than before.

CAMBRIDGE, Mass. — The Food and Drug Administration has approved a vaccine against meningococcal disease for use among patients of a broader age range than before.

March 22, 2013

Disease relapse rates and worsening of disability were low among patients taking a drug made by Genzyme for multiple sclerosis, the company said.

CAMBRIDGE, Mass. — Disease relapse rates and worsening of disability were low among patients taking a drug made by Genzyme for multiple sclerosis, the company said.

Genzyme, a division of French drug maker Sanofi, announced results of an extension study of the drug Lemtrada (alemtuzumab). The study was a follow-up to two other late-stage clinical studies of the drug, finding that relapse rates and sustained accumulation of disability remained low among patients who had previously received the drug.

January 28, 2013

The Food and Drug Administration has accepted a regulatory approval application from Genzyme for an experimental treatment for multiple sclerosis, the company said Monday.

CAMBRIDGE, Mass. — The Food and Drug Administration has accepted a regulatory approval application from Genzyme for an experimental treatment for multiple sclerosis, the company said Monday.

Genzyme, a division of French drug maker Sanofi, said the FDA accepted its application seeking approval for Lemtrada (alemtuzumab) for relapsing MS. The company expects the agency to decide whether to approve the drug in the second half of this year.

October 19, 2012

Improving medication adherence may be the key to reducing hospital re-admission rates, according to a new issue brief by a health policy research organization.

CAMBRIDGE, Mass. — Improving medication adherence may be the key to reducing hospital re-admission rates, according to a new issue brief by a health policy research organization.

October 16, 2012

Target should be feeling confident about its upcoming entry into Canada, as a recent survey from Kantar Retail and TNS Canada revealed that 75% of Canadians are aware of the retailer.

CAMBRIDGE, Mass. — Target should be feeling confident about its upcoming entry into Canada, as a recent survey from Kantar Retail and TNS Canada revealed that 75% of Canadians are aware of the retailer.

Furthermore, 43% of Canadian consumers said that they were likely to shop at Target Canada for grocery or health and beauty aids and 50% were likely to shop at Target Canada for general merchandise or apparel.

October 9, 2012

A drug maker and a hospital have entered an agreement aimed at developing new treatments for various types of hematological malignancies and solid tumors.

CAMBRIDGE, Mass. — A drug maker and a hospital have entered an agreement aimed at developing new treatments for various types of hematological malignancies and solid tumors.

Sanofi and Massachusetts General Hospital said their project-based collaboration unites scientists from the respective parties, with the goal of "maximizing the strengths of both academic and industry cross-organizational expertise, and will include both preclinical and clinical translational research to elucidate questions from proof-of-concept to tolerability, efficacy and effectiveness."

October 8, 2012

Dollar General is the overall basket price leader, delivering a substantial savings to value shoppers, according to Kantar Retail's second annual opening price point survey.

CAMBRIDGE, Mass. — Dollar General is the overall basket price leader, delivering a substantial savings to value shoppers, according to Kantar Retail's second annual opening price point survey. Walgreens, for the second year, had the most expensive total basket, driven by sharply higher edible and nonedible grocery baskets.

October 2, 2012

An experimental drug for treating a rare genetic disease appears effective, according to a late-stage clinical trial.

CAMBRIDGE, Mass. — An experimental drug for treating a rare genetic disease appears effective, according to a late-stage clinical trial.

September 13, 2012

The Food and Drug Administration has approved a new drug for multiple sclerosis.

CAMBRIDGE, Mass. — The Food and Drug Administration has approved a new drug for multiple sclerosis.

Sanofi subsidiary Genzyme announced that the FDA had approved Aubagio (teriflunomide) as a once-daily, oral treatment for patients with relapsing MS.

September 10, 2012

A drug maker and medical research institute will work together to identify new treatments for bacterial and viral infections.

CAMBRIDGE, Mass. — A drug maker and medical research institute will work together to identify new treatments for bacterial and viral infections.

AstraZeneca and the Broad Institute, owned jointly by Harvard University and MIT, announced Monday that they would collaborate for two years to develop medicines to treat severe infections, saying the identification of high-quality chemicals for the development of new drugs was a significant challenge. The two will use the Broad Institute's collection of 100,000 chemicals known as diversity-oriented synthesis, or DOS compounds.